Titlebook: Breast Cancer: Scientific and Clinical Progress; Proceedings of the B Marvin A. Rich,Jean C. Hager,Diana M. Lopez Conference proceedings 19

Immunoglobulin

https://doi.org/10.1007/978-94-010-2619-2on-toxic aromatase inhibitors could potentially provide effective therapy for a number of estrogen-dependent diseases. Clinical application of these agents depends upon the physiologic source of estrogen and the ability of regulatory systems to counteract the effects of these inhibitors. Consequentl

laxative

Human Monoclonal Antibodies Directed Against Viral Antigensact with MMTV have been identified in sera of 20% to 60% of patients with breast cancer (3–11). Despite the facts pointing to the existence of the relationship between MMTV and human breast cancer, contradicting results have been described (17).

一起

Breast Cancer Differentiation and Progression: Analysis with Monoclonal Antibodies Flow Cytometrymbrane were discussed first, basolateral cell surface antigens and intracellular antigens were the next topics. Some studies on the prognostic value of antigen expression were presented at the end of this discussion.